Skip to main content
SpringerLink
Log in

ACEI inhibitors and ARBs do not increase severity of COVID-19

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Li J, et al. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. JAMA Cardiology : 23 Apr 2020. Available from: URL: http://dx.doi.org/10.1001/jamacardio.2020.1624

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ACEI inhibitors and ARBs do not increase severity of COVID-19. Reactions Weekly 1802, 5 (2020). https://doi.org/10.1007/s40278-020-77923-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77923-x

Search

Navigation